Education
About Us
Working with TipRanks
Follow Us
InMode (INMD)
NASDAQ:INMD
INMD Stock Chart & Stats
$14.45
-$1.18(-6.78%)
At close: 4:00 PM EST
$14.45
-$1.18(-6.78%)
Day’s Range― - ―
52-Week Range$13.14 - $19.85
Previous CloseN/A
Volume968.14K
Average Volume (3M)743.75K
Market Cap
$1.01B
Enterprise Value$424.92M
Total Cash (Recent Filing)$532.31M
Total Debt (Recent Filing)$5.59M
Price to Earnings (P/E)6.7
Beta1.15
Next Earnings
Feb 05, 2026EPS Estimate
0.42Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.38
Shares Outstanding69,558,670
10 Day Avg. Volume655,501
30 Day Avg. Volume743,746
Financial Highlights & Ratios
PEG Ratio-2.16
Price to Book (P/B)1.88
Price to Sales (P/S)3.35
P/FCF Ratio10.03
Enterprise Value/Market Cap0.42
Enterprise Value/Revenue0.86
Enterprise Value/Gross Profit1.08
Enterprise Value/Ebitda2.85
Forecast
1Y Price Target
$17.67Price Target Upside22.28% Upside
Rating ConsensusHold
Number of Analyst Covering5
EPS Forecast (FY)1.58
Revenue Forecast (FY)$369.96M
Bulls Say, Bears Say
Bulls Say
Business InvestmentINMD is investing in its business and restructuring its sales team to penetrate market segments more deeply.
Financial PerformanceINMD expects its 3Q25 gross margin to be in the range of 77-79% vs. consensus of 68.3%.
Product DemandA shift toward noninvasive platforms highlights increasing demand for lower-cost procedures, positioning INMD well to capture evolving consumer preferences.
Bears Say
Economic ChallengesMacro challenges have pressured the company, despite beating top-line expectations and maintaining revenue guidance.
Geopolitical RisksGeopolitical risks, including tariff considerations and the war in Israel, remain a concern for INMD.
Revenue DeclineINMD's revenue declined 29% in 3Q25 compared to 11% growth in 2Q25.
InMode News
INMD FAQ
What was InMode’s price range in the past 12 months?
InMode lowest stock price was $13.14 and its highest was $19.85 in the past 12 months.
What is InMode’s market cap?
InMode’s market cap is $1.01B.
When is InMode’s upcoming earnings report date?
InMode’s upcoming earnings report date is Feb 05, 2026 which is in 88 days.
How were InMode’s earnings last quarter?
InMode released its earnings results on Nov 05, 2025. The company reported $0.38 earnings per share for the quarter, beating the consensus estimate of $0.355 by $0.025.
Is InMode overvalued?
According to Wall Street analysts InMode’s price is currently Undervalued.
Does InMode pay dividends?
InMode does not currently pay dividends.
What is InMode’s EPS estimate?
InMode’s EPS estimate is 0.42.
How many shares outstanding does InMode have?
InMode has 69,558,670 shares outstanding.
What happened to InMode’s price movement after its last earnings report?
InMode reported an EPS of $0.38 in its last earnings report, beating expectations of $0.355. Following the earnings report the stock price went down -0.684%.
Which hedge fund is a major shareholder of InMode?
Currently, no hedge funds are holding shares in INMD
InMode Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$17.67 (22.28% Upside)
$17.67 (22.28% Upside)
Blogger Sentiment
Bullish
INMD Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 1.5M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.2%
Last 30 Days ▼ 3.6%
Last 30 Days ▼ 3.6%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-25.06%
12-Months-Change
Fundamentals
Return on Equity
21.52%
Trailing 12-Months
Asset Growth
-10.85%
Trailing 12-Months
Company Description
InMode
InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was incorporated in 2008 and is headquartered in Yokneam, Israel.
INMD Company Deck
INMD Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Negative
The earnings call presented a mix of positive developments, such as international expansion and strong consumables growth, but these were overshadowed by significant declines in revenue, gross margins, operating margins, and net income compared to the previous year.View all INMD earnings summariesINMD Stock 12 Month Forecast
Average Price Target
$17.67
▲(22.28% Upside)
Technical Analysis
Orthofix
―
AxoGen
―
Establishment Labs Holdings
―
SS Innovations International
―
Bioventus
―
Ownership Overview
―
Insiders
6.26% Mutual Funds
0.04% Other Institutional Investors
91.18% Public Companies and Individual Investors